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Rheumatoid arthritis (RA) is a well and widely recognized cause of carpal tunnel syndrome
(CTS). In the rheumatoid wrist, synovial expansion, joint erosions and ligamentous laxity
result in compression of the median nerve due to increased intracarpal pressure. We  evalu-
ated the published studies to determine the prevalence of CTS and the characteristics of the
median nerve in RA and its association with clinical parameters such as disease activity, dis-
ease duration and seropositivity. A total of 13 studies met the eligibility criteria. Pooled data
from 8 studies with random selection of RA patients revealed that 86 out of 1561 (5.5%) sub-
jects  had CTS. Subclinical CTS, on the other hand, had a pooled prevalence of 14.0% (30/215).
The  cross sectional area of the median nerve of the RA patients without CTS were similar to
the  healthy controls. The vast majority of the studies (8/13) disclosed no signiﬁcant relation-
ship  between the median nerve ﬁndings and the clinical or laboratory parameters in RA. The
link between RA and the median nerve abnormalities has been overemphasized throughout
the  literature. The prevalence of CTS in RA is similar to the general population without any
correlation between the median nerve characteristics and the clinical parameters of RA.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
O  envolvimento  do  nervo  mediano  na  artrite  reumatoide  tem  sido
excessivamente  valorizado?
alavras-chave:
r  e  s  u  m  o
A artrite reumatoide (AR) é uma causa bem e amplamente reconhecida de síndrome do túnel
ervo mediano
rtrite reumatoide
índrome do túnel do carpo
do  carpo (STC). No punho acometido pela artrite reumatoide, a expansão sinovial, as erosões
articulares e a frouxidão ligamentar resultam em compressão do nervo mediano decorrente
do  aumento da pressão intracarpal. Avaliaram-se os estudos publicados para determi-Please cite this article in press as: Sakthiswary R, Singh R. Has the median nerve involvement in rheumatoid arthritis been overemphasized?
Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.09.001
nar a prevalência de STC e as características do nervo mediano na AR e sua associac¸ão
com  parâmetros clínicos, como a atividade e durac¸ão da doenc¸a e a soropositividade.
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255-5021/© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
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Preencheram os critérios de elegibilidade 13 estudos. Os dados agrupados dos oito estudos
com  selec¸ão aleatória de pacientes com AR revelaram que 86 de 1.561 (5,5%) indivíduos tin-
ham STC. Por outro lado, a STC subclínica teve uma prevalência combinada de 14% (30/215).
A  área de sec¸ão transversa do nervo mediano dos pacientes com AR sem STC foi semelhante
à  de controles saudáveis. A grande maioria dos estudos (8/13) não apresentou relac¸ão signi-
ﬁcativa entre os achados no nervo mediano e os parâmetros clínicos ou laboratoriais na AR.
A  ligac¸ão entre a AR e as anormalidades do nervo mediano foi excessivamente valorizada
em  toda a literatura. A prevalência de STC na AR é semelhante à da populac¸ão em geral,
sem qualquer correlac¸ão entre as características do nervo mediano e os parâmetros clínicos
da AR.
© 2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC
BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
267 articles identified
245 excluded
: 16 - Other languages
: 46 - Case reports
- Unrelated studies/did not meet
inclusion criteria : 183 
8 excluded
: 8
- Unrelated studies/did not meet
inclusion criteria        
22 articles for full text article retrieval
14 studies included
Fig. 1 – The algorithm for selection of studies in this
systematic review.Introduction
Beyond the joints, rheumatoid arthritis (RA) may present with
extra-articular manifestations such as pulmonary ﬁbrosis,
subcutaneous nodules and peripheral neuropathy in up to
10–20% of patients.1 The wrist is the most frequently affected
joint in RA with carpal tunnel syndrome (CTS) as a potential
sequelae. In the rheumatoid wrist, synovial expansion, joint
erosions and ligamentous laxity result in loss of carpal tunnel
height and increased carpal tunnel pressure. This contributes
to impaired axonal transport, compression of the median
nerve and vessels in the perineurium causing median nerve
ischemia.2,3 The other plausible culprit mechanisms that have
been implicated in rheumatoid neuropathy are drug toxicity,
vasculitis and amyloidosis.4
Carpal tunnel syndrome (CTS) is by and large a clinical
diagnosis, although electrophysiological tests (nerve conduc-
tion studies [NCS], electromyography [EMG]) and sonographic
assessment of the median nerve may be useful to sup-
port the diagnosis, detect subclinical CTS and rule out other
abnormalities.5 Unfortunately, the neuropathic pain in RA is
often overlooked and mistaken for arthritic pain.6
Hart et al. was the ﬁrst to describe neuropathy in RA in
year 1957.7 Since then, several electrophysiological and sono-
graphic studies have examined the median nerve in RA with
variable ﬁndings. The purpose of this systematic review, is
therefore, to summarize the results of these studies and to
determine in RA the prevalence of CTS, characteristics of the
median nerve and its association with the clinical parameters
such as disease activity, disease duration and seropositivity.
Methods
Search  strategy
We  searched the literature for clinical studies on median
nerve in RA using the following databases: Science Direct,
Pubmed/Medline, Ovid, ISI Web of Knowledge, EBSCO and Sco-
pus. These search terms used were “rheumatoid arthritis”,Please cite this article in press as: Sakthiswary R, Singh R. Has the media
Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.09.001
“median nerve,” “carpal tunnel syndrome” and “neuropathy”.
To ensure completeness, we went through papers not only on
CTS explicitly but also on less speciﬁc conditions that might
encompass the median nerve/CTS like peripheral neuropathy.The abstracts of the studies were scrutinized for appropriate-
ness before retrieving the full text of the articles. We  searched
the bibliographies of all relevant published articles to avoid
missing other relevant studies. Fig. 1 summarizes the algo-
rithm used for selection of the studies. Ethics approval was
not required for this systematic review as there was no recruit-
ment of subjects or research intervention.
Selection  criteria
Inclusion  criteria
The search was further reﬁned to achieve a high level of
homogeneity across the selected studies. We  applied a time
restriction to studies published from year 1980 onwards. We
included studies about RA which:
1. examined the median nerve characteristics (sonographic
and/or electrophysiological),n nerve involvement in rheumatoid arthritis been overemphasized?
2. were about CTS,
3. were published in English.
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xclusion  criteria
e  excluded case reports and review articles. Studies on
eripheral neuropathy which did not provide speciﬁc data on
he median nerve were not considered either.
ata  extraction
he following data were extracted from all studies included in
his systematic review: study design, study population includ-
ng the details of the control arm, sample size, prevalence
f CTS in RA, median nerve characteristics in RA (sono-
raphic and electrophysiological), the relationship between
he median nerve characteristics and the clinical parameters.
he relevant and especially signiﬁcant statistical values (p and
 values) were recorded.
esults
 total of 13 studies.6,8–19 met  the eligibility criteria. Majority
f the studies (12/13) were cross-sectional, and there were 5
ase-control studies.9,10,12,13,18 The controls employed by the
tudies were either healthy individuals9,10,13,18 or RA patients
ithout symptoms of CTS.9 Study sample sizes varied from
314 to 107016 subjects. Two of the studies11,14 dealt with sub-
linical CTS i.e. conducted among subjects without signs and
ymptoms of CTS. Tables 1 and 2 highlight the ﬁndings of the
elected studies.
revalence  of  CTS  in  RA
n most studies, the diagnosis of CTS was based on a combi-
ation of symptoms (paraesthesia, tingling sensation, pain at
he median nerve innervated area), signs (positive Tinel’s or
halen test) and electrophysiological ﬁndings. The exact diag-
ostic criteria and deﬁnition of CTS used across the studies
ere quite diverse. Hammer et al.12 deﬁned CTS based on a
alm-to-wrist median sensory nerve action potential (SNAP)
nset latency of >2.0 ms  or absence of SNAP and median distal
otor latency of >4.9 ms  whereas Sim et al.18 deﬁned CTS as
 palm to wrist median nerve latency of less than 50%. The
revalence of CTS in RA ranged from 3.5%16 to 22.8%.17 Pooled
ata from 8 studies6,8,9,13,15–17,19 with random selection of RA
atients revealed that 86 out of 1561 (5.5%) subjects had CTS.
ubclinical CTS, on the other hand, had a pooled prevalence
f 14.0% (30/215) (Table 2).
onographic  ﬁndings  of  the  median  nerve  in  RA
ross-sectional area (CSA) of the median nerve was deter-
ined using ultrasound scan in 3 of the studies.11–13 Two
ut of 3 of these studies12,13 were of case–control design with
ealthy individuals as controls. Hammer et al.11 investigated
A patients without signs and symptoms of CTS. The CSA of
he bilateral median nerve of the RA patients without CTS
ere similar to the healthy controls. The mean (standard devi-Please cite this article in press as: Sakthiswary R, Singh R. Has the media
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tion) of the right median nerve in asymptomatic RA patients
as 8.3 (1.5) mm2 whereas for the left median nerve was 8.3
1.4) mm2.11 The CSA of the median nerve in CTS patients were
igniﬁcantly higher with a median of 15.7 mm2 (11.1–21.8).12 6;x  x x(x x):xxx–xxx 3
Electrophysiological  ﬁndings  of  the  median  nerve  in  RA
Electrophysiological assessment of the median nerve was car-
ried out in 10/136,8–10,12,14–16,18,19 of the studies. Details of the
NCS in terms of the median nerve velocity, amplitude and
latency were provided only by 2 studies i.e. Lanzillo et al.10
and Calder et al.15 The former study reported that the median
nerve sensory conduction velocity was reduced by 25.2% along
the distal nerve segment in 57.5% of RA patients compared
to the general population. The amplitude of the sensory
responses was signiﬁcantly reduced at the wrist and elbow
in 17.5% and 5% of patients, respectively. Distal latency to
the abductor pollicis brevis muscle was signiﬁcantly slower
in 10% of the patients whereas the maximum velocity from
the elbow to the wrist was prolonged by 12% in almost a
quarter of the subjects. Calder et al.,10 found that the median
nerve SNAP amplitude was signiﬁcantly lower in the RA and
hand osteoarthritis groups compared to the healthy controls
(p < 0.05) but there were no appreciable differences in the
median nerve SNAP conduction velocity and latency between
the RA patients and the healthy controls. It is noteworthy that
this study had an extremely small sample size with only 8 RA
patients.
Correlation  between  the  median  nerve  characteristics  and
the clinical  parameters
Across the studies, the most frequently assessed clinical
parameter was disease duration (9/13 studies)6,8,11,13–18 as
compared to disease activity (4/13 studies).6,8,9,13 Apart from
the above mentioned, the following clinical and labora-
tory parameters were commonly analyzed by the selected
studies; age, height, weight, medications, rheumatoid fac-
tor (RF), erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP). Approximately half of these studies were
designed to compare the patients’ characteristics between
RA patients with and without CTS13,16 or with and without
neuropathy.6,8,17,18 The vast majority of the studies (8/13) dis-
closed no signiﬁcant relationship between the median nerve
involvement and clinical or laboratory parameters in RA. How-
ever, Karadag et al.13 and Biswas et al.6 revealed a signiﬁcant
association between disease duration and the occurrence of
CTS (p = 0.036) and neuropathy (p = 0.001), respectively. Like-
wise, 2 studies found that age was signiﬁcantly higher among
RA patients with CTS13 and peripheral neuropathy.18
Discussion
Rheumatoid arthritis (RA) is often cited in the literature as
one of the common etiologies of CTS. This systematic review,
however, highlights that the pooled prevalence of CTS in RA
was 5.5% which did not differ signiﬁcantly from the prevalence
in the general population which ranged from 2.7 to 5.8%.20,21
We  could have underestimated the prevalence in this regard
as a sizable proportion (1070/1561) of the subjects included in
16n nerve involvement in rheumatoid arthritis been overemphasized?
the pooled analysis were from a retrospective study. Retro-
spective studies, in general, are notorious for underreporting
due to missing or omitted data.22,23 In parallel with the afore-
mentioned ﬁnding, our pooled prevalence of subclinical CTS of
Please cite this article in press as: Sakthiswary R, Singh R. Has the median nerve involvement in rheumatoid arthritis been overemphasized?
Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.09.001
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Table 1 – Summary of the selected studies of CTS in RA.
Ref. Test(s) Study population Prevalence
of CTS in RA
n (%)
Clinical and
laboratory
parameters
Findings
Lanzillo et al.,
1998
NCS of peripheral
nerves
40  RA patients 5 (12.5%) Age, disease
duration, steroid
therapy, functional
stage
The electrophysiologic
ﬁndings were unrelated to
clinical features of RA.
Sivri et al.,
1999
NCS  and
somatosensorial
evoked potential
studies
33 RA patients and
20 healthy controls
2  (6%) No correlation between
neuropathy and the clinical
variables.
Sakini et al.,
2005
NCS, EMG 80 RA patients 8 (22.8%) Disease duration There was no association
between disease duration
and the occurrence of
neuropathy.
Hammer
et al., 2006
US  of the median
nerves at the
entrance of the
carpal tunnel, NCS,
Tinel’s and Phalen’s
tests.
7  RA patients with
CTS symptoms
5 patients with other
forms of arthritis
with CTS symptoms
Controls: 30 RA
patients without
symptoms of CTS &
30 healthy controls
Height,  weight CSA of the median nerves
were signiﬁcantly higher in
the CTS patients compared
with the RA controls and
healthy persons; median
(range) areas were
15.7 mm2 (11.1–21.8),
8.5 mm2 (5.8–11.0) and
8.0 mm2 (4.9–12.0),
respectively (p < 0.0001).
No signiﬁcant correlation
between CSA of median
nerve and clinical
parameters in the RA
group. Healthy controls had
signiﬁcant correlation
between CSA of median
nerve and height (r = 0.6,
p < 0.001) and weight
(r = 0.43, p = 0.001)
Agarwal
et al., 2008
NCS of peripheral
nerves
108  RA patients 11 (10.1%) Absence of deep
tendon jerks,
extra-articular
manifestations
(interstitial lung
disease, vasculitis,
subcutaneous
nodules), disease
duration, RF, joint
erosions, joint
deformities,
DMARDs or
glucocorticoid
intake, and disease
activity, abdominal
fat pad for amyloid
Absence of deep tendon
jerks (p < 0.005) and
vasculitis (p < 0.01) were
conspicuous in the
neuropathic group. There
was no relationship
between neuropathy and
other parameters.
Aktekin et al.,
2009
EMG and NCS of the
peripheral nerves
56  RA patients
32 healthy controls
2  (4%) Corticosteroid
therapy, Schirmer’s
test, RF, disease
activity
There was no correlation
between electrophysiologic
ﬁndings and the other
study parameters.
Biswas et al.,
2011
NCS of the
peripheral nerves
74  RA patients 3 (10.3) Age, disease
duration, disease
activity, RF,
interstitial lung
disease,
subcutaneous
nodules, vasculitis,
corticosteroids,
DMARDs and joint
erosions
Disease duration and RF
positivity was signiﬁcantly
higher in patients with
neuropathy (p = 0.001 for
both). No signiﬁcant
difference in other
parameters between
patients with and without
neuropathy.
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Table 1 – (Continued)
Ref. Test(s) Study population Prevalence
of CTS in RA
n (%)
Clinical and
laboratory
parameters
Findings
Calder et al.,
2012
NCS of the
peripheral nerves,
sensory mapping
(SM), vibratory and
current perception
thresholds (VPT and
CPT) of the 2nd and
5th digits
7  women with RA
9 healthy women
11 women with
hand OA
All  SNAP amplitudes were
signiﬁcantly lower for the
hand OA and hand RA
groups compared with the
healthy group (p < 0.05). No
group differences were
found for SNAP conduction
velocities, SM, VPT, and
CPT.
Karadag
et al., 2012
Katz hand diagram,
Boston CTS
questionnaire,
Phalen and Tinel
tests.
US of wrist joints
and carpal tunnel
gray scale and power
Doppler.
Patients with
median nerve CSA
between 10.0 and
13.0 mm2 were
evaluated with
electromyography
(EMG)
100 RA patients
45 healthy controls
18  (18%) Age, gender, body
mass index, disease
duration, goiter,
disease activity,
HAQ-DI, ESR, CRP,
CTS global
assessment, CTS
symptom duration,
Boston symptom
severity score,
Boston functional
status
In  RA group with CTS: age
(57 [36–73] vs. 50 [24–76],
p = 0.041), history of DM
(35.3% vs. 6.0%, p < 0.001),
disease duration (108
[12–396] months vs. 72
[6–360] months, p = 0.036),
HAQ-DI score (1.93
[0.75–2.87] vs. 1.13 [0–2.75],
p = 0.013), CTS patient
global score (52 [1–97] vs. 25
[0–91], p = 0.001), Boston
symptom severity (2.81
[1.18–4.17] vs. 2.0 [1.0–4.01],
p = 0.01) and functional
status scores (3.37 [1.37–5.0]
vs. 2.25 [1.0–5.0], p = 0.008)
were elevated compared to
patients without CTS.
Sim et al.,
2014
NCS, Neuropathic
Symptoms Scale
(NSS)
30  RA patients with
symptoms of
peripheral
neuropathy
7  (23.3%) Age, anti-CCP, the
type of medication,
disease duration,
functional status,
neuropathic
symptoms, ESR, CRP
The mean ages of the
patients with and without
peripheral neuropathy were
69.4 and 56.5 years,
respectively (p < 0.05).
Lee et al.,
2015
EMG, NCS, Phalen’s
and Tinel’s tests
1070 RA patients 37 (3.5%) CRP, disease
duration
There was no statistically
signiﬁcant correlation
between CTS occurrence
and duration of RA and CRP
levels.
EMG, electromyography; NCS, nerve conduction studies; RF, rheumatoid factor; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein;
CTS, carpal tunnel syndrome; RA, rheumatoid arthritis; HAQ-DI, Health Assessment Questionnaire – disability index; OA, osteoarthritis; DMARD,
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odisease modifying antirheumatic drug.
4.0% was within the reported range in the general population
f 7–16%.24
In healthy individuals, the mean CSA of the median nerve
t the level of entrance into the carpal tunnel, which has the
ighest diagnostic sensitivity and speciﬁcity for CTS, has been
ound to be between 7.0 ± 1.0 mm2 and 10.2 ± 2.5 mm2.25–27
he mean CSA of the median nerve in RA patients without
igns and symptoms of CTS were similar to healthy controls.
his lends credence to the notion that the chronic inﬂamma-
ory processes in RA do not affect the size of the median nerve
espite the close proximity between the median nerve and
he wrist joint. However, Yagci et al.28 had contradicting ﬁnd-Please cite this article in press as: Sakthiswary R, Singh R. Has the media
Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.09.001
ngs of RA patients having larger CSA of the median nerve
espite absence of clinical and neurophysiological evidence
f CTS.No ﬁrm conclusions can be made on the electrophysi-
ological changes of the median nerve in RA owing to the
paucity of studies in this regard and the conﬂicting ﬁndings
of the existing studies. Although Lanzillo et al.15 revealed that
more than half of RA patients without symptoms of CTS had
reduced median nerve sensory conduction velocity along the
distal nerve segment, this study failed to demonstrate any
correlation between the clinical parameters of RA and the elec-
trophysiological ﬁndings. Of note, this study had the drawback
of not having a control arm and therefore, comparison was
made with data from other published studies.
We found that there is no conclusive and convincing proofn nerve involvement in rheumatoid arthritis been overemphasized?
of association between the clinical or laboratory parameters
in RA and the median nerve involvement. Although Karadag
et al.,13 disclosed that age, disease duration and functional
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Table 2 – Summary of the selected studies of subclinical CTS in RA.
Reference Test(s) Study population Prevalence of
subclinical
CTS in RA
n (%)
Clinical and
laboratory
parameters
Findings
Lang et al., 1981 NCS of 6
sensory
nerves
23 RA
patients
5  (21.7%) Age, gender,
disease duration,
stage of disease,
RF, ESR.
No  signiﬁcant correlation between
neurophysiological/neurological
ﬁndings and other study
parameters.
Hammer et al., 2007 US of the
median
nerves at the
entrance of
the carpal
tunnel
154 RA
patients
without signs
and
symptoms of
CTS
10% Height, weight,
age, gender,
disease duration,
use of
prednisolone.
The  CSA of the median nerves
ranged from 5.0 to 12.8 mm2, with
the 97.5 centile being 11.1 mm2.
The mean cross-sectional areas of
the median nerve in patients with
RA were similar to those reported
in healthy controls.
No signiﬁcant association between
CSA of median nerve and all
studied parameters except for
gender; males were signiﬁcantly
higher (8.8 ± 1.3 mm2 versus
females: 8.0 ± 1.4 mm2 [p, 0.001]
cyte 
r
1
1NCS, nerve conduction studies; RF, rheumatoid factor; ESR, erythro
arthritis.
scores were higher among the RA patients with CTS, the
remaining studies were not in agreement with the above
ﬁndings. However, numerous studies which investigated the
extra-articular manifestations of RA, in general, identiﬁed
the following factors as predictors in this regard: high dis-
ease activity, smoking, antinuclear antibodies and rheumatoid
nodules.29,30
The studies included in this systematic review were not
without their individual limitations. In particular, many  had
a small sample size, hence limiting the statistical power.
Many  of the studies did not fully control for confounding
factors of CTS such as occupation, the presence of dia-
betes mellitus and hypothyroidism. Deﬁnition of CTS varied
substantially across the studies. Misclassiﬁcation as CTS, par-
ticularly among studies that diagnosed CTS solely based on
symptoms, was another potential source of error.
In conclusion, the nexus between RA and the median nerve
abnormalities or CTS has been overemphasized throughout
the literature. Based on this systematic review, a substantial
body of research suggests that the prevalence of CTS in RA
is similar to the general population without any correlation
between the median nerve ﬁndings and the clinical parame-
ters of RA.
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